Reasonable results, but a lot of hits and misses; coronavirus impacts guidance.

Limp growth and a sluggish inflation outlook provide a favourable backdrop for credit in 2020.

A long road lies ahead as the trial continues, but we are maintaining our fair value estimates for the two healthcare firms, says Morningstar’s Anna Baran.

The national carrier joins an exclusive club after its surprise move to tap investors for more capital.

And in the meantime, online idea discovery site Pinterest may benefit, says Morningstar.

American and global growth will contract by just 1 per cent, according to long-term forecasts.

The annuities provider this week announced a $300m capital raise to shore up its balance sheet and shift to lower risk credit assets.

An offer that most investors should refuse.

Lockdowns and social distancing saw customers emptying shelves, but earnings growth still eludes the supermarket giant.

Its record run has seduced retail investors, but fund managers are less willing to jump on.

Disappointing retail participation in National Australia Bank’s $3.5 billion capital raising in April highlights a flawed system that favours the big end of town.

Three global names in energy and brewing share compelling characteristics: a two-decade competitive advantage, exemplary leadership and value.

These companies achieve high Minority Empowerment Scores because they have demonstrated a strong commitment to diversity and inclusion.

Offloading its medical centre and dental business will allow the healthcare company to pay down debt and focus on the turnaround of other units

These names from the Morningstar Exponential Technologies Index are trading at 4-star levels.